Relive the excitement of the Patriots’ path to their fourth Super Bowl Championship with “Pumped”, a special commemorative book from The Boston Globe. Order now.

Infinity completes 5.7m share offering

Adelene Q. Perkins is the chief executive of Infinity.

Bill Greene/Globe Staff/File 2012

Adelene Q. Perkins is the chief executive of Infinity.

Continue reading below

Cambridge-based Infinity ­Pharmaceuticals Inc. said that its 5.7 million-share offering priced flat with Wednesday’s close of $26.33, as it seeks to raise funds for research and ­development costs, potential acquisitions and other purposes, Dow Jones reported. Infinity’s shares had climbed to their highest level in a decade on Tuesday after the company ­reported positive results from an early clinical trial of its drug IPI-145 as a treatment for blood cancers.

Loading comments...

Wake up with today's top stories.

Want each day's news headlines delivered fresh to your
inbox every morning? Just connect with us
in one of the following ways:
or
Please enter a valid email
BostonGlobe.com will never post anything without asking. Privacy Policy
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com